The trademark application Gralexon was filed by Bausch Health Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on March 20, 2023, and it was registered by office on June 27, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1730003 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).